<DOC>
<DOCNO>
EP-0000074
</DOCNO>
<TEXT>
<DATE>
19781220
</DATE>
<IPC-CLASSIFICATIONS>
C07D-471/00 A61P-9/00 A61K-31/435 C07D-471/08 A61P-9/06 <main>C07D-471/08</main> A61K-31/445 
</IPC-CLASSIFICATIONS>
<TITLE>
new bispidine derivatives, process for their preparation and medicinal preparations containing them.
</TITLE>
<APPLICANT>
basf agde<sep>basf aktiengesellschaft<sep>basf aktiengesellschaftcarl-bosch-strasse 3867063 ludwigshafende<sep>basf aktiengesellschaft<sep>
</APPLICANT>
<INVENTOR>
binnig fritz dr<sep>friedrich ludwig dr <sep>hofmann hans peter dr<sep>kreiskott horst dr  <sep>mueller claus dr<sep>raschack manfred dr<sep>binnig, fritz, dr.<sep>friedrich, ludwig, dr.<sep>hofmann, hans peter, dr.<sep>kreiskott, horst, dr.<sep>mueller, claus, dr.<sep>raschack, manfred, dr.<sep>binnig, fritz, dr.raiffeisenstrasse 31d-6701 fussgoenheimde<sep>friedrich, ludwig, dr.nibelungenstrasse 8ad-6831 brühlde<sep>hofmann, hans peter, dr.thorwaldsenstrasse 3d-6700 ludwigshafende<sep>kreiskott, horst, dr.am boehligd-6706 wachenheimde<sep>mueller, claus, dr.odenwaldring 84d-6806 viernheimde<sep>raschack, manfred, dr.donnersbergstrasse 7d-6714 weisenheimde<sep>binnig, fritz, dr.<sep>friedrich, ludwig, dr.<sep>hofmann, hans peter, dr.<sep>kreiskott, horst, dr.<sep>mueller, claus, dr. <sep>raschack, manfred, dr.<sep>binnig, fritz, dr. raiffeisenstrasse 31 d-6701 fussgoenheim de <sep>friedrich, ludwig, dr.nibelungenstrasse 8ad-6831 brühlde<sep>hofmann, hans peter, dr.thorwaldsenstrasse 3d-6700 ludwigshafende<sep>kreiskott, horst, dr.am boehligd-6706 wachenheimde<sep>mueller, claus, dr.odenwaldring 84d-6806 viernheimde<sep>raschack, manfred, dr.donnersbergstrasse 7d-6714 weisenheimde<sep>
</INVENTOR>
<ABSTRACT>
The present invention relates to bispidine derivatives of the formula wherein R¹ is H or C₆H₅, R² H, C1 or CF₃, R³ H, F, or C1, and X 0 or 1, and medicaments containing these compounds.The compounds are prepared by condensation of N monobezylbispidine with correspondingly substituted phenylethylhalides or by Mannich reaction of n-benxyl-piperidone-4 with correspondingly substituted phenylalkylamines and subsequent reduction.The new compounds have predominantly antiarrhythmic properties.
</ABSTRACT>
</TEXT>
</DOC>
